ArticleCancer medicine2026

Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese Cohort.

Lijia Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.